Literature DB >> 27118629

A comparison of change point models with application to longitudinal lung function measurements in children with cystic fibrosis.

Angela Moss1, E Juarez-Colunga1,2, Farouk Nathoo3, Brandie Wagner2, Scott Sagel4.   

Abstract

Cystic fibrosis (CF) is a hereditary lung disease characterized by loss of lung function over time. Lung function in CF is believed to decline at a higher rate during the adolescence period. It has been also hypothesized that there is a subgroup of individuals for whom lung disease remains relatively stable with only a slight decline over their lifetime. Using data from the University of Colorado CF Children's Registry, we investigate four change point models to model the decline of lung function in children and adolescents: (i) a two-component mixture random change point model, (ii) a two-component mixture-fixed change point model, (iii) a random change point model, and (iv) a fixed change point model. The models are investigated through posterior predictive simulation at the individual and population levels, and a simulation study examining the effects of model misspecification. The data support the mixed random change point model as the preferred model, with roughly 30% of adolescents experiencing a steady decline of 0.5 %FEV1 per year and 70% experiencing an increase in decline of 4.4 %FEV1 per year beginning on average at 14.6 years of age.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  broken stick models; joinpoint models; marginal likelihood; mixture models; piecewise models

Mesh:

Year:  2016        PMID: 27118629     DOI: 10.1002/sim.6845

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  14 in total

1.  Joint hierarchical Gaussian process model with application to personalized prediction in medical monitoring.

Authors:  Leo L Duan; Xia Wang; John P Clancy; Rhonda D Szczesniak
Journal:  Stat (Int Stat Inst)       Date:  2018-03-04

Review 2.  Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher.

Authors:  Rhonda Szczesniak; Sonya L Heltshe; Sanja Stanojevic; Nicole Mayer-Hamblett
Journal:  J Cyst Fibros       Date:  2017-01-20       Impact factor: 5.482

3.  Phenotypes of Rapid Cystic Fibrosis Lung Disease Progression during Adolescence and Young Adulthood.

Authors:  Rhonda D Szczesniak; Dan Li; Weiji Su; Cole Brokamp; John Pestian; Michael Seid; John P Clancy
Journal:  Am J Respir Crit Care Med       Date:  2017-08-15       Impact factor: 21.405

4.  Dynamics of Disease Progression and Gastrostomy Tube Placement in Children and Adolescents with Cystic Fibrosis: Application of Joint Models for Longitudinal and Time-to-Event Data.

Authors:  Rhonda Szczesniak; Weiji Su; J P Clancy
Journal:  Intern Med Rev (Wash D C)       Date:  2016-10

5.  An empirical comparison of segmented and stochastic linear mixed effects models to estimate rapid disease progression in longitudinal biomarker studies.

Authors:  Weiji Su; Emrah Gecili; Xia Wang; Rhonda D Szczesniak
Journal:  Stat Biopharm Res       Date:  2021-02-04       Impact factor: 1.452

6.  Shared parameter models for joint analysis of longitudinal and survival data with left truncation due to delayed entry - Applications to cystic fibrosis.

Authors:  Mark D Schluchter; Annalisa V Piccorelli
Journal:  Stat Methods Med Res       Date:  2018-04-04       Impact factor: 3.021

7.  Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients.

Authors:  Douglas J Conrad; Barbara A Bailey; Jon A Hardie; Per S Bakke; Tomas M L Eagan; Bernt B Aarli
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

8.  Bayesian Piecewise Linear Mixed Models With a Random Change Point: An Application to BMI Rebound in Childhood.

Authors:  Samuel L Brilleman; Laura D Howe; Rory Wolfe; Kate Tilling
Journal:  Epidemiology       Date:  2017-11       Impact factor: 4.822

9.  Risk factor identification in cystic fibrosis by flexible hierarchical joint models.

Authors:  Weiji Su; Xia Wang; Rhonda D Szczesniak
Journal:  Stat Methods Med Res       Date:  2020-08-25       Impact factor: 3.021

10.  An Animated Functional Data Analysis Interface to Cluster Rapid Lung Function Decline and Enhance Center-Level Care in Cystic Fibrosis.

Authors:  Jesse Pratt; Weiji Su; Don Hayes; John P Clancy; Rhonda D Szczesniak
Journal:  J Healthc Eng       Date:  2021-05-10       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.